JP2003335380A - Package with oxygen indicator function - Google Patents
Package with oxygen indicator functionInfo
- Publication number
- JP2003335380A JP2003335380A JP2002143890A JP2002143890A JP2003335380A JP 2003335380 A JP2003335380 A JP 2003335380A JP 2002143890 A JP2002143890 A JP 2002143890A JP 2002143890 A JP2002143890 A JP 2002143890A JP 2003335380 A JP2003335380 A JP 2003335380A
- Authority
- JP
- Japan
- Prior art keywords
- oxygen
- package
- gas
- indicator function
- cysteine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title claims abstract description 118
- 239000001301 oxygen Substances 0.000 title claims abstract description 118
- 229910052760 oxygen Inorganic materials 0.000 title claims abstract description 118
- 239000007789 gas Substances 0.000 claims abstract description 76
- 239000005022 packaging material Substances 0.000 claims abstract description 51
- 239000003814 drug Substances 0.000 claims abstract description 49
- 235000013305 food Nutrition 0.000 claims abstract description 24
- 238000007639 printing Methods 0.000 claims abstract description 24
- 229940123973 Oxygen scavenger Drugs 0.000 claims abstract description 12
- 229940079593 drug Drugs 0.000 claims description 37
- 239000000203 mixture Substances 0.000 claims description 32
- 238000000034 method Methods 0.000 claims description 26
- 238000004806 packaging method and process Methods 0.000 claims description 26
- 238000001514 detection method Methods 0.000 claims description 25
- 239000000243 solution Substances 0.000 claims description 22
- 239000003638 chemical reducing agent Substances 0.000 claims description 19
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims description 18
- 235000018417 cysteine Nutrition 0.000 claims description 18
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 claims description 17
- 239000007793 ph indicator Substances 0.000 claims description 17
- 229940024606 amino acid Drugs 0.000 claims description 14
- 235000001014 amino acid Nutrition 0.000 claims description 14
- 150000001413 amino acids Chemical class 0.000 claims description 14
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 14
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 12
- 229960002433 cysteine Drugs 0.000 claims description 11
- 229960003067 cystine Drugs 0.000 claims description 11
- 239000000975 dye Substances 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000001016 thiazine dye Substances 0.000 claims description 10
- 150000001945 cysteines Chemical class 0.000 claims description 9
- COHYTHOBJLSHDF-BUHFOSPRSA-N indigo dye Chemical compound N\1C2=CC=CC=C2C(=O)C/1=C1/C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-BUHFOSPRSA-N 0.000 claims description 9
- 235000000346 sugar Nutrition 0.000 claims description 9
- 229930003231 vitamin Natural products 0.000 claims description 9
- 239000011782 vitamin Substances 0.000 claims description 9
- 235000013343 vitamin Nutrition 0.000 claims description 9
- 229940088594 vitamin Drugs 0.000 claims description 9
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims description 8
- 238000000576 coating method Methods 0.000 claims description 8
- 229940097275 indigo Drugs 0.000 claims description 8
- 239000011248 coating agent Substances 0.000 claims description 7
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 7
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 7
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 7
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 7
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 7
- 229960000907 methylthioninium chloride Drugs 0.000 claims description 7
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 7
- 239000004378 Glycyrrhizin Substances 0.000 claims description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 4
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 claims description 4
- IFQSXNOEEPCSLW-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride Chemical compound Cl.SCC(N)C(O)=O IFQSXNOEEPCSLW-UHFFFAOYSA-N 0.000 claims description 3
- XUJNEKJLAYXESH-UWTATZPHSA-N D-Cysteine Chemical compound SC[C@@H](N)C(O)=O XUJNEKJLAYXESH-UWTATZPHSA-N 0.000 claims description 3
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims description 3
- 239000004158 L-cystine Substances 0.000 claims description 3
- 235000019393 L-cystine Nutrition 0.000 claims description 3
- 229960004308 acetylcysteine Drugs 0.000 claims description 3
- JROURLWMOZCGJV-UHFFFAOYSA-N alizarin blue Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C1=CC=CN=C1C(O)=C2O JROURLWMOZCGJV-UHFFFAOYSA-N 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 230000003115 biocidal effect Effects 0.000 claims description 3
- 229940078469 dl- cysteine Drugs 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 3
- 229940061262 ethyl cysteine hydrochloride Drugs 0.000 claims description 3
- KHLVKKOJDHCJMG-QDBORUFSSA-L indigo carmine Chemical compound [Na+].[Na+].N/1C2=CC=C(S([O-])(=O)=O)C=C2C(=O)C\1=C1/NC2=CC=C(S(=O)(=O)[O-])C=C2C1=O KHLVKKOJDHCJMG-QDBORUFSSA-L 0.000 claims description 3
- 229960003988 indigo carmine Drugs 0.000 claims description 3
- 235000012738 indigotine Nutrition 0.000 claims description 3
- 239000004179 indigotine Substances 0.000 claims description 3
- 229930182817 methionine Natural products 0.000 claims description 3
- YYGBVRCTHASBKD-UHFFFAOYSA-M methylene green Chemical compound [Cl-].C1=CC(N(C)C)=C([N+]([O-])=O)C2=[S+]C3=CC(N(C)C)=CC=C3N=C21 YYGBVRCTHASBKD-UHFFFAOYSA-M 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- IFQSXNOEEPCSLW-HSHFZTNMSA-N (2s)-2-amino-3-sulfanylpropanoic acid;hydron;chloride Chemical compound Cl.SC[C@@H](N)C(O)=O IFQSXNOEEPCSLW-HSHFZTNMSA-N 0.000 claims description 2
- HICSZRHAFWZDGQ-UHFFFAOYSA-N 2-(5-bromo-3-hydroxy-1H-indol-2-yl)indol-3-one Chemical compound Oc1c([nH]c2ccc(Br)cc12)C1=Nc2ccccc2C1=O HICSZRHAFWZDGQ-UHFFFAOYSA-N 0.000 claims description 2
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 claims description 2
- AGIJRRREJXSQJR-UHFFFAOYSA-N 2h-thiazine Chemical compound N1SC=CC=C1 AGIJRRREJXSQJR-UHFFFAOYSA-N 0.000 claims description 2
- 229930195710 D‐cysteine Natural products 0.000 claims description 2
- WHOHXJZQBJXAKL-DFWYDOINSA-N Mecysteine hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)CS WHOHXJZQBJXAKL-DFWYDOINSA-N 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 claims 1
- GBFLZEXEOZUWRN-VKHMYHEASA-N S-carboxymethyl-L-cysteine Chemical compound OC(=O)[C@@H](N)CSCC(O)=O GBFLZEXEOZUWRN-VKHMYHEASA-N 0.000 claims 1
- 230000007257 malfunction Effects 0.000 claims 1
- NZYCYASKVWSANA-UHFFFAOYSA-M new methylene blue Chemical compound [Cl-].CCNC1=C(C)C=C2N=C(C=C(C(NCC)=C3)C)C3=[S+]C2=C1 NZYCYASKVWSANA-UHFFFAOYSA-M 0.000 claims 1
- 238000007789 sealing Methods 0.000 abstract description 18
- 230000007547 defect Effects 0.000 abstract description 5
- -1 cystine compound Chemical class 0.000 description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 10
- 235000013361 beverage Nutrition 0.000 description 9
- 239000004698 Polyethylene Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000000463 material Substances 0.000 description 7
- 229920000573 polyethylene Polymers 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 229920002451 polyvinyl alcohol Polymers 0.000 description 6
- 239000011230 binding agent Substances 0.000 description 5
- 229910001873 dinitrogen Inorganic materials 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000002845 discoloration Methods 0.000 description 4
- 239000003978 infusion fluid Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000000123 paper Substances 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000009461 vacuum packaging Methods 0.000 description 4
- 229920002799 BoPET Polymers 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000003113 alkalizing effect Effects 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000007646 gravure printing Methods 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 229920001684 low density polyethylene Polymers 0.000 description 3
- 239000004702 low-density polyethylene Substances 0.000 description 3
- 229960004452 methionine Drugs 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000565 sealant Substances 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000004201 L-cysteine Substances 0.000 description 2
- 235000013878 L-cysteine Nutrition 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- GBFLZEXEOZUWRN-VKHMYHEASA-M S-carboxylatomethyl-L-cysteine(1-) Chemical compound [O-]C(=O)[C@@H]([NH3+])CSCC([O-])=O GBFLZEXEOZUWRN-VKHMYHEASA-M 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- SQHOAFZGYFNDQX-UHFFFAOYSA-N ethyl-[7-(ethylamino)-2,8-dimethylphenothiazin-3-ylidene]azanium;chloride Chemical compound [Cl-].S1C2=CC(=[NH+]CC)C(C)=CC2=NC2=C1C=C(NCC)C(C)=C2 SQHOAFZGYFNDQX-UHFFFAOYSA-N 0.000 description 2
- 239000005038 ethylene vinyl acetate Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229960002449 glycine Drugs 0.000 description 2
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 2
- 229920000092 linear low density polyethylene Polymers 0.000 description 2
- 239000004707 linear low-density polyethylene Substances 0.000 description 2
- 239000002960 lipid emulsion Substances 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 238000007650 screen-printing Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000002344 surface layer Substances 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 2
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CCBICDLNWJRFPO-UHFFFAOYSA-N 2,6-dichloroindophenol Chemical compound C1=CC(O)=CC=C1N=C1C=C(Cl)C(=O)C(Cl)=C1 CCBICDLNWJRFPO-UHFFFAOYSA-N 0.000 description 1
- OYCLSQDXZMROJK-UHFFFAOYSA-N 2-bromo-4-[3-(3-bromo-4-hydroxyphenyl)-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]phenol Chemical compound C1=C(Br)C(O)=CC=C1C1(C=2C=C(Br)C(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 OYCLSQDXZMROJK-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- RUKISNQKOIKZGT-UHFFFAOYSA-N 2-nitrodiphenylamine Chemical compound [O-][N+](=O)C1=CC=CC=C1NC1=CC=CC=C1 RUKISNQKOIKZGT-UHFFFAOYSA-N 0.000 description 1
- JKYKXTRKURYNGW-UHFFFAOYSA-N 3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(O)=C(O)C(S(O)(=O)=O)=C2 JKYKXTRKURYNGW-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- ZPLCXHWYPWVJDL-UHFFFAOYSA-N 4-[(4-hydroxyphenyl)methyl]-1,3-oxazolidin-2-one Chemical compound C1=CC(O)=CC=C1CC1NC(=O)OC1 ZPLCXHWYPWVJDL-UHFFFAOYSA-N 0.000 description 1
- OLQIKGSZDTXODA-UHFFFAOYSA-N 4-[3-(4-hydroxy-2-methylphenyl)-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]-3-methylphenol Chemical compound CC1=CC(O)=CC=C1C1(C=2C(=CC(O)=CC=2)C)C2=CC=CC=C2S(=O)(=O)O1 OLQIKGSZDTXODA-UHFFFAOYSA-N 0.000 description 1
- LRBZENFZSJNJCR-UHFFFAOYSA-N 5-bromo-2-(5-bromo-3-hydroxy-1H-indol-2-yl)indol-3-one Chemical compound [O-]c1c([nH]c2ccc(Br)cc12)C1=[NH+]c2ccc(Br)cc2C1=O LRBZENFZSJNJCR-UHFFFAOYSA-N 0.000 description 1
- 208000032484 Accidental exposure to product Diseases 0.000 description 1
- RGCKGOZRHPZPFP-UHFFFAOYSA-N Alizarin Natural products C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- RGWSDXBNHPAZFV-UHFFFAOYSA-N BrC=1C(=C(C(=C(C1)C(C)C)O)C)C(Br)(Br)Br.BrC=1C(=C(C=CC1)O)Br Chemical compound BrC=1C(=C(C(=C(C1)C(C)C)O)C)C(Br)(Br)Br.BrC=1C(=C(C=CC1)O)Br RGWSDXBNHPAZFV-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- 229930195722 L-methionine Natural products 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 1
- IDIDJDIHTAOVLG-VKHMYHEASA-N S-methylcysteine Chemical compound CSC[C@H](N)C(O)=O IDIDJDIHTAOVLG-VKHMYHEASA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- QQOPAWAPLFHEEP-UHFFFAOYSA-M [7-(dimethylamino)-2-methylphenoxazin-3-ylidene]-diethylazanium;chloride Chemical compound [Cl-].O1C2=CC(N(C)C)=CC=C2N=C2C1=CC(=[N+](CC)CC)C(C)=C2 QQOPAWAPLFHEEP-UHFFFAOYSA-M 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- RRNJROHIFSLGRA-JEDNCBNOSA-N acetic acid;(2s)-2,6-diaminohexanoic acid Chemical compound CC(O)=O.NCCCC[C@H](N)C(O)=O RRNJROHIFSLGRA-JEDNCBNOSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- HFVAFDPGUJEFBQ-UHFFFAOYSA-M alizarin red S Chemical compound [Na+].O=C1C2=CC=CC=C2C(=O)C2=C1C=C(S([O-])(=O)=O)C(O)=C2O HFVAFDPGUJEFBQ-UHFFFAOYSA-M 0.000 description 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000008148 cardioplegic solution Substances 0.000 description 1
- FYGDTMLNYKFZSV-ZWSAEMDYSA-N cellotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-ZWSAEMDYSA-N 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- OBRMNDMBJQTZHV-UHFFFAOYSA-N cresol red Chemical compound C1=C(O)C(C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C=C(C)C(O)=CC=2)=C1 OBRMNDMBJQTZHV-UHFFFAOYSA-N 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229960001305 cysteine hydrochloride Drugs 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 1
- ZWJINEZUASEZBH-UHFFFAOYSA-N fenamic acid Chemical compound OC(=O)C1=CC=CC=C1NC1=CC=CC=C1 ZWJINEZUASEZBH-UHFFFAOYSA-N 0.000 description 1
- CIWXFRVOSDNDJZ-UHFFFAOYSA-L ferroin Chemical compound [Fe+2].[O-]S([O-])(=O)=O.C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 CIWXFRVOSDNDJZ-UHFFFAOYSA-L 0.000 description 1
- 239000005357 flat glass Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- DBTMGCOVALSLOR-AXAHEAMVSA-N galactotriose Natural products OC[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@H](O)O[C@@H](CO)[C@@H]3O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O DBTMGCOVALSLOR-AXAHEAMVSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229920000554 ionomer Polymers 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000005001 laminate film Substances 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 238000007644 letterpress printing Methods 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- QTWZICCBKBYHDM-UHFFFAOYSA-N leucomethylene blue Chemical compound C1=C(N(C)C)C=C2SC3=CC(N(C)C)=CC=C3NC2=C1 QTWZICCBKBYHDM-UHFFFAOYSA-N 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- FZWBNHMXJMCXLU-YRBKNLIBSA-N manninotriose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-YRBKNLIBSA-N 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- SHXOKQKTZJXHHR-UHFFFAOYSA-N n,n-diethyl-5-iminobenzo[a]phenoxazin-9-amine;hydrochloride Chemical compound [Cl-].C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=[NH2+])C2=C1 SHXOKQKTZJXHHR-UHFFFAOYSA-N 0.000 description 1
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000007645 offset printing Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000003330 peritoneal dialysis fluid Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 239000011112 polyethylene naphthalate Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 description 1
- SOUHUMACVWVDME-UHFFFAOYSA-N safranin O Chemical compound [Cl-].C12=CC(N)=CC=C2N=C2C=CC(N)=CC2=[N+]1C1=CC=CC=C1 SOUHUMACVWVDME-UHFFFAOYSA-N 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- PRZSXZWFJHEZBJ-UHFFFAOYSA-N thymol blue Chemical compound C1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C(=CC(O)=C(C(C)C)C=2)C)=C1C PRZSXZWFJHEZBJ-UHFFFAOYSA-N 0.000 description 1
- 210000004746 tooth root Anatomy 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000003232 water-soluble binding agent Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- NLIVDORGVGAOOJ-MAHBNPEESA-M xylene cyanol Chemical compound [Na+].C1=C(C)C(NCC)=CC=C1C(\C=1C(=CC(OS([O-])=O)=CC=1)OS([O-])=O)=C\1C=C(C)\C(=[NH+]/CC)\C=C/1 NLIVDORGVGAOOJ-MAHBNPEESA-M 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Landscapes
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Packages (AREA)
Abstract
(57)【要約】
【課 題】 脱酸素雰囲気となる包装体において、ピ
ンホールおよびシール不良などの発生によるガス雰囲気
の変化を簡単に確認し得る酸素インジケーター機能付き
包装体を提供する。
【解決手段】 酸素で変質しやすい医薬または食品を収
容したガス透過性容器を、ガス非透過性包装材にて包装
してなり、かつ、包装体内がガス置換、真空、または脱
酸素剤によって脱酸素雰囲気となっている包装体におい
て、上記包装材の不具合による包装体のガス雰囲気変化
を色調変化で検知する酸素検知部を印刷によって備えて
いることを特徴とする酸素インジケーター機能付き包装
体。(57) [Summary] [Problem] To provide a package with an oxygen indicator function that can easily confirm a change in gas atmosphere due to the occurrence of pinholes and poor sealing in a package in a deoxidized atmosphere. SOLUTION: A gas permeable container containing a medicine or food which is liable to be deteriorated by oxygen is packaged in a gas impermeable packaging material, and the inside of the package is degassed by gas replacement, vacuum, or oxygen scavenger. A package having an oxygen indicator function, characterized in that the package having an oxygen atmosphere is provided with printing an oxygen detecting portion for detecting a change in the gas atmosphere of the package by a change in color tone due to a defect of the packaging material.
Description
【0001】[0001]
【発明の属する技術分野】本発明は、医薬、薬品、食品
(飲料を含む)などを長期間保存するための包装体に関
する。より詳細には、酸素検知部を印刷により備えたこ
とを特長とする酸素インジケーター機能付き包装体に関
する。TECHNICAL FIELD The present invention relates to a package for storing medicines, medicines, foods (including beverages), etc. for a long period of time. More specifically, the present invention relates to a package with an oxygen indicator function, which is provided with an oxygen detector by printing.
【0002】[0002]
【従来の技術】医薬、薬品、食品(飲料を含む)などの
内容物の酸化を防止し、長期間保存する一般的な方法と
して、ガス置換包装がある。ガス置換包装とは、例え
ば、置換するガスとして窒素を用い、ガス非透過性の優
れた包装材料で包装するものである。このように、ガス
非透過性の優れた包装材料を用い、ガス置換包装を行う
ことにより、内容物を長期間保存することが可能とな
る。しかし、包装材料自体の欠陥、または内容物封入時
の失敗、あるいは流通などの運搬過程における衝撃など
が原因で、ピンホールやシール不良などが発生した場合
には、ガス置換包装された雰囲気が変化し、内容物の腐
敗、または変質が生じることがあり、また、ガス置換包
装された雰囲気の変化に気づかないまま流通される恐れ
があった。このように、ガス非透過性の優れた包装材料
を用い、ガス置換包装を行っても、ピンホール、シール
不良などを確認する手段がなく、内容物がガス置換包装
雰囲気中に確実に保存されているかどうかわからなかっ
た。2. Description of the Related Art Gas substitution packaging is a general method for preventing the contents such as medicines, medicines, foods (including beverages) from being oxidized and storing them for a long time. The gas replacement packaging is, for example, a method in which nitrogen is used as a replacement gas and packaging is performed with a packaging material having excellent gas impermeability. As described above, the contents can be stored for a long period of time by performing the gas displacement packaging using the packaging material having excellent gas impermeability. However, if pinholes or poor seals occur due to defects in the packaging material itself, failure to fill the contents, or impact during transportation such as distribution, the atmosphere in which the gas is replaced is changed. However, the contents may be decomposed or deteriorated, and the gas may be distributed without noticing the change in the atmosphere filled with the gas. In this way, even when gas displacement packaging is performed using packaging materials with excellent gas impermeability, there is no means to confirm pinholes, poor sealing, etc., and the contents are reliably stored in the gas displacement packaging atmosphere. I didn't know if it was.
【0003】そこで、上記の問題点を改善するために酸
素の存在の有無により色相を変化する酸素インジケータ
ーを含有する包装体が開発されている。従来、酸素イン
ジケーターとしては、錠剤化したものを個別に包装し、
医薬または食品を外部の酸素を遮断してガス非透過性の
フィルムの小袋に包装し、包装された錠剤を包装体内に
投入することにより酸素の有無を判定する。しかし、従
来の錠剤化したものは、(1)個々に錠剤を包装しなけ
ればならない、(2)錠剤が崩壊した場合、小袋に空け
た穴をとおして崩壊した粉末が外部へ流出する、(3)
医薬品においては錠剤の誤飲により医療過誤につなが
る、(4)錠剤を包装体内に固定することが困難であ
る、(5)錠剤が包装体内で動き、外部から目視検知し
にくいなどの種々の問題点を有していた。Therefore, in order to solve the above problems, a package containing an oxygen indicator which changes its hue depending on the presence or absence of oxygen has been developed. Conventionally, as an oxygen indicator, tablets are individually packaged,
The presence or absence of oxygen is determined by packaging a medicine or food in a small bag of a gas impermeable film by blocking external oxygen, and inserting the packaged tablet into a package. However, in the conventional tableted product, (1) the tablets must be individually packaged, (2) when the tablets are disintegrated, the disintegrated powder flows out through the holes in the pouch, ( 3)
In the case of pharmaceuticals, various problems such as accidental ingestion of tablets leading to medical malpractice, (4) it is difficult to fix the tablets inside the package, (5) the tablets move inside the package, and are difficult to be visually detected from the outside. Had a point.
【0004】[0004]
【発明が解決しようとする課題】本発明は、脱酸素雰囲
気となる包装体において、ピンホールおよびシール不良
などの発生による包装体内のガス雰囲気の変化を簡単に
確認し得る酸素インジケーター機能付き包装体を提供す
ることにある。DISCLOSURE OF THE INVENTION The present invention provides a package with an oxygen indicator function, which can easily confirm the change in the gas atmosphere in the package due to the occurrence of pinholes, poor sealing, etc. To provide.
【0005】[0005]
【課題を解決するための手段】本発明者らは、上記課題
を解決するため鋭意検討した結果、酸素で変質しやすい
医薬または食品を収容したガス透過性容器を、ガス非透
過性包装材で包装し、酸素検知部を印刷によって備えた
酸素インジケーター機能付き包装体とすることにより、
上記の問題点を一挙に解決することができることを見出
し、さらに検討を重ねて、本発明を完成させるに至っ
た。Means for Solving the Problems As a result of intensive studies to solve the above-mentioned problems, the present inventors have developed a gas-permeable container containing a drug or food that is easily deteriorated by oxygen with a gas-impermeable packaging material. By wrapping it and making it a packaging body with an oxygen indicator function equipped with an oxygen detection part by printing,
The inventors have found that the above problems can be solved all at once, and have conducted further studies to complete the present invention.
【0006】すなわち、本発明は、(1) 酸素で変質
しやすい医薬または食品を収容したガス透過性容器を、
ガス非透過性包装材にて包装してなり、かつ、包装体内
がガス置換、真空、または脱酸素剤によって脱酸素雰囲
気となっている包装体において、上記包装材の不具合に
よる包装体のガス雰囲気変化を色調変化で検知する酸素
検知部を印刷によって備えていることを特徴とする酸素
インジケーター機能付き包装体、(2) 酸素で変質し
やすい医薬または食品がアミノ酸薬液、糖質薬液、ビタ
ミン含有薬液、重炭酸塩薬液、脂肪乳剤、および抗生物
質製剤からなる群から選択される一種または二種以上で
あることを特徴とする前記(1)に記載の酸素インジケ
ーター機能付き包装体、(3) 酸素で変質しやすい医
薬または食品がグリチルリチン製剤であることを特徴と
する前記(1)または(2)に記載の酸素インジケータ
ー機能付き包装体、(4) 酸素検知部が還元性物質お
よびpH指示薬を含む水溶液または有機溶媒溶液を含有
するインキ組成物によって形成される塗膜であることを
特徴とする前記(1)から(3)のいずれかに記載の酸
素インジケーター機能付き包装体、(5) 還元性物質
が還元性アミノ酸類、還元性ビタミン類または還元糖類
であることを特徴とする前記(4)に記載の酸素インジ
ケーター機能付き包装体、(6) 還元性物質がシステ
イン類またはシスチン類であり、pH指示薬がチアジン
系色素および/またはインジゴ系色素であることを特徴
とする前記(4)または(5)に記載の酸素インジケー
ター機能付き包装体、(7) システイン類またはシス
チン類の濃度が100〜100000ppmであること
を特徴とする前記(6)に記載の酸素インジケーター機
能付き包装体、(8) システイン類またはシスチン類
がL−システイン、L−システイン塩酸塩、DL−シス
テイン、DL−システイン塩酸塩、D−システイン、D
−システイン塩酸塩、塩酸L−エチルシステイン、塩酸
L−メチルシステイン、アセチルシステイン、S−カル
ボキシメチル−L−システイン、L−シスチンからなる
群から選択される一種または二種以上であることを特徴
とする前記(6)または(7)に記載の酸素インジケー
ター機能付き包装体、(9) チアジン系色素および/
またはインジゴ系色素の濃度が100〜100000p
pmであることを特徴とする前記(6)に記載の酸素イ
ンジケーター機能付き包装体、(10) チアジン系色
素またはインジゴ系色素がウルトラバイオレット、アズ
レC、アズレB、メチレンブルー、メチオニンブルー、
ニューメチレンブルー、メチレングリーン、ラウスバイ
オレット、ネオメチレンブルー、ブリリアントアリザリ
ンブルー、インジゴ、インジゴカルミン、ブロムインジ
ゴRからなる群から選択される一種または二種以上であ
ることを特徴とする前記(6)または(9)に記載の酸
素インジケーター機能付き包装体、(11) 印刷がガ
ス透過性容器の外側またはガス非透過性包装材の内側に
表示されていることを特徴とする前記(1)から(1
0)のいずれかに記載の酸素インジケーター機能付き包
装体、(12) 酸素検知部がピンホール検知部である
ことを特徴とする前記(1)から(11)のいずれかに
記載の酸素インジケーター機能付き包装体、(13)
前記(1)から(12)のいずれかに記載の酸素インジ
ケーター機能付き包装体のガス透過性容器に収納されて
いる酸素で変質しやすい医薬または食品、(14) 酸
素で変質しやすい医薬または食品を前記(1)から(1
2)のいずれかに記載の酸素インジケーター機能付き包
装体のガス透過性容器に収納し、保存することを特徴と
する酸素で変質しやすい医薬または食品の保存方法、に
関する。[0006] That is, the present invention provides (1) a gas permeable container containing a drug or food which is easily deteriorated by oxygen,
In a package which is packaged in a gas impermeable packaging material and has a deoxygenated atmosphere in the package due to gas replacement, vacuum, or an oxygen scavenger, the gas atmosphere of the package due to a defect of the packaging material A packaging body with an oxygen indicator function, which is equipped with an oxygen detection unit for detecting changes by color change by printing, (2) A drug or food easily altered by oxygen is an amino acid drug solution, a sugar drug solution, or a vitamin-containing drug solution. , A bicarbonate drug solution, a fat emulsion, and one or more kinds selected from the group consisting of antibiotic preparations, and the oxygen indicator function-equipped package according to (1) above, (3) oxygen In the packaging body with an oxygen indicator function according to the above (1) or (2), wherein the medicine or food that is easily denatured is a glycyrrhizin preparation. 4) In any one of the above (1) to (3), wherein the oxygen detection part is a coating film formed by an ink composition containing an aqueous solution containing a reducing substance and a pH indicator or an organic solvent solution. (5) The packaging body with an oxygen indicator function according to (4), wherein the reducing substance is a reducing amino acid, a reducing vitamin or a reducing saccharide, 6) The packaging body with an oxygen indicator function according to the above (4) or (5), wherein the reducing substance is cysteine or cystine and the pH indicator is a thiazine dye and / or an indigo dye. (7) The oxygen indicator according to (6) above, wherein the concentration of cysteines or cystines is 100 to 100,000 ppm. Ta function package, (8) cysteines or cystine compound is L- cysteine, L- cysteine hydrochloride, DL-cysteine, DL-cysteine hydrochloride, D- cysteine, D
-One or more selected from the group consisting of cysteine hydrochloride, L-ethylcysteine hydrochloride, L-methylcysteine hydrochloride, acetylcysteine, S-carboxymethyl-L-cysteine and L-cystine. A package with an oxygen indicator function according to the above (6) or (7), (9) a thiazine dye and / or
Or the concentration of indigo dye is 100 to 100000p
(10) A package with an oxygen indicator function according to the above (6), wherein the thiazine dye or the indigo dye is ultra violet, Azure C, Azure B, methylene blue, methionine blue,
(6) or (9), which is one or more selected from the group consisting of new methylene blue, methylene green, rous violet, neomethylene blue, brilliant alizarin blue, indigo, indigo carmine, and bromindigo R. (11) A package with an oxygen indicator function according to (1) above, wherein the print is displayed on the outside of the gas permeable container or on the inside of the gas impermeable packaging material.
Oxygen indicator function packaging according to any one of (0), (12) Oxygen indicator function according to any one of (1) to (11), characterized in that the oxygen detection unit is a pinhole detection unit With packaging, (13)
A medicine or food which is easily deteriorated by oxygen contained in the gas permeable container of the package with an oxygen indicator function according to any one of (1) to (12), (14) A medicine or food which is easily deteriorated by oxygen From (1) to (1
(2) A method for storing a drug or food that is easily deteriorated by oxygen, characterized by storing and storing in a gas-permeable container of the package with an oxygen indicator function described in any of (2).
【0007】[0007]
【発明の実施の形態】本発明の酸素インジケーター機能
付き包装体は酸素検知部を印刷により備えていることを
特長とする。酸素検知部は、好ましくは、インキ組成物
をガス透過性容器またはガス非透過性包装材上に印刷す
ることによって形成される塗膜である。また、酸素検知
部は、好ましくは、ピンホール検知部である。このイン
キ組成物は、包装体内雰囲気中に酸素が存在すると、色
調が変化する。この色調の変化を包装体の外部から目視
観察することにより、包装体内雰囲気の酸素濃度の変化
を酸素検知部の色調により判断して、包装体のピンホー
ル、およびシール不良などの発生を簡単に確認すること
ができる。BEST MODE FOR CARRYING OUT THE INVENTION The package with an oxygen indicator function of the present invention is characterized in that an oxygen detecting portion is provided by printing. The oxygen detection part is preferably a coating film formed by printing the ink composition on a gas permeable container or a gas impermeable packaging material. Further, the oxygen detector is preferably a pinhole detector. The color tone of this ink composition changes when oxygen is present in the atmosphere in the package. By visually observing the change in color tone from the outside of the package, the change in oxygen concentration in the atmosphere inside the package can be judged by the color tone of the oxygen detection part, and pinholes in the package and defective sealing can be easily generated. You can check.
【0008】インキ組成物は、好ましくは、還元性物
質、pH指示薬、溶媒、結合剤、水分などから構成され
る。The ink composition is preferably composed of a reducing substance, a pH indicator, a solvent, a binder, water and the like.
【0009】還元性物質としては、特に限定されるもの
ではないが、好ましくは、例えば、還元性アミノ酸類、
還元性ビタミン類または還元糖類などが挙げられる。還
元性アミノ酸類としては、例えば、システイン類、シス
チン類などが挙げられる。還元性ビタミン類としては、
例えば、ビタミンE、ビタミンA、ビタミンCなどが挙
げられる。還元糖類としては、例えば、ブドウ糖、フル
クトース、ガラクトース、キシロース、マンノースなど
の単糖類、マルトース、ラクトース、セロビオースなど
の二糖類、マルトトリオース、セロトリオース、マンニ
ノトリオースなどの三糖類などが挙げられる。さらに、
ブドウ糖に異性化酵素を作用させて得られる異性化糖、
および澱粉を酸や酵素で加水分解して得られる水あめな
どの混合物なども挙げられる。The reducing substance is not particularly limited, but preferably, for example, reducing amino acids,
Examples include reducing vitamins or reducing sugars. Examples of the reducing amino acids include cysteines and cystines. As reducing vitamins,
For example, vitamin E, vitamin A, vitamin C, etc. may be mentioned. Examples of the reducing sugars include monosaccharides such as glucose, fructose, galactose, xylose and mannose, disaccharides such as maltose, lactose and cellobiose, and trisaccharides such as maltotriose, cellotriose and manninotriose. further,
Isomerized sugar obtained by acting an isomerase on glucose,
And a mixture such as starch syrup obtained by hydrolyzing starch with an acid or an enzyme.
【0010】還元性物質としては、好ましくは、システ
イン類またはシスチン類を用いる。システイン類または
シスチン類としては、L−体、DL−体、D−体のいず
れも用いることができる。また、L−体、DL−体、D
−体の他、その塩類、エステル、N−アシル誘導体など
も用いることができる。その塩類としては、例えば塩酸
塩が挙げられる。また、そのエステルとしては、例え
ば、メチルエステル、エチルエステルなどのアルキルエ
ステルなどが挙げられる。N−アシル誘導体としては、
アセチル誘導体、ベンゾイル誘導体などが挙げられる。
これらのシステイン類、シスチン類の具体例としては、
例えば、L−システイン、L−システイン塩酸塩、DL
−システイン、DL−システイン塩酸塩、D−システイ
ン、D−システイン塩酸塩、塩酸L−エチルシステイ
ン、塩酸、L−メチルシステイン、アセチルシステイ
ン、S−カルボキシメチル−L−システイン、L−シス
チンなどを挙げることができる。これらは、その一種を
単独で用いることもでき、また、二種以上を併用するこ
ともできる。なお、システイン類またはシスチン類は
熱、光に対して安定であることに加え、従来にない強い
還元性を有するため、下記するpH指示薬の配合比を高
めることが可能となる。As the reducing substance, cysteines or cystines are preferably used. As cysteines or cystines, any of L-form, DL-form and D-form can be used. In addition, L-body, DL-body, D
In addition to the -form, its salts, esters, N-acyl derivatives and the like can be used. Examples of the salts include hydrochloride. Examples of the ester include alkyl esters such as methyl ester and ethyl ester. As the N-acyl derivative,
Examples include acetyl derivatives and benzoyl derivatives.
Specific examples of these cysteines and cystines include:
For example, L-cysteine, L-cysteine hydrochloride, DL
-Cysteine, DL-cysteine hydrochloride, D-cysteine, D-cysteine hydrochloride, L-ethylcysteine hydrochloride, hydrochloric acid, L-methylcysteine, acetylcysteine, S-carboxymethyl-L-cysteine, L-cystine and the like. be able to. One of these may be used alone, or two or more thereof may be used in combination. Since cysteines or cystines are stable against heat and light and have a strong reducibility that has not been heretofore available, it is possible to increase the compounding ratio of the pH indicator described below.
【0011】例えば、システイン類またはシスチン類な
どの還元性物質の濃度は特に限定されるものではない
が、約100〜約100000ppmの範囲であること
が好ましい。For example, the concentration of the reducing substance such as cysteine or cystine is not particularly limited, but it is preferably in the range of about 100 to about 100,000 ppm.
【0012】pH指示薬としては、色調の変化が目視で
簡単に確認できるものが好ましい。例えば、メチレンブ
ルー、ロイコメチレンブルー、2,6−ジクロロフェノ
ールインドフェノール、メチルフェナゾニウムメタサル
フェイト、クレゾールバイオレット、ピオシアニン、レ
サズリン、インジゴ、m−クレゾールパープル、チモー
ルブルー、クレゾールレッド、フェノールフタレイン、
ブロモチモールブルー、フェノールレッド、ジブロムフ
ェノールテトラブロム、メチルチモールブルー、アリザ
リン、キシリトールオレンジ、ブロモフェノールレッ
ド、コンゴーレッド、アリザリンスルホン酸ナトリウ
ム、ニュートラルレッド、サフラニンT、フェノサフラ
ニン、カプリブルー、ナイルブルー、ジフェニルアミ
ン、キシレンシアノール、ニトロジフェニルアミン、フ
ェロイン、N−フェニルアントラニル酸などを挙げるこ
とができる。より好ましくは、メチレンブルーなどのチ
アジン系色素、または、インジゴなどのインジゴ系色素
を挙げることができる。The pH indicator is preferably one that allows the change in color tone to be easily confirmed visually. For example, methylene blue, leuco methylene blue, 2,6-dichlorophenol indophenol, methylphenazonium metasulfate, cresol violet, piocyanine, resazurin, indigo, m-cresol purple, thymol blue, cresol red, phenolphthalein,
Bromothymol blue, phenol red, dibromophenol tetrabrom, methylthymol blue, alizarin, xylitol orange, bromophenol red, congo red, sodium alizarin sulfonate, neutral red, safranin T, phenosafranin, capri blue, nile blue, diphenylamine , Xylene cyanol, nitrodiphenylamine, ferroin, N-phenylanthranilic acid and the like. More preferably, a thiazine dye such as methylene blue or an indigo dye such as indigo can be used.
【0013】チアジン系色素およびインジゴ系色素とし
ては、酸素が存在している状態の色調が、無酸素状態で
無色ないし他の色調に変化する色素が好ましい。チアジ
ン系色素の例としては、例えば、ウルトラバイオレッ
ト、アズレC、アズレB、メチレンブルー、メチオニン
ブルー、ニューメチレンブルー、メチレングリーン、ラ
ウスバイオレット、ネオメチレンブルー、ブリリアント
アリザリンブルーなどを挙げることができる。インジゴ
系色素の例としては、例えば、インジゴ、インジゴカル
ミン、ブロムインジゴRなどを挙げることができる。こ
れらの色素もその一種を単独で用いてもよく、二種以上
を併用してもよい。As the thiazine-based dye and the indigo-based dye, dyes whose color tone in the presence of oxygen changes to colorless or another color tone in the anoxic state are preferable. Examples of thiazine dyes include ultra violet, Azure C, Azure B, methylene blue, methionine blue, new methylene blue, methylene green, rous violet, neomethylene blue, and brilliant alizarin blue. Examples of indigo dyes include indigo, indigo carmine, and bromoindigo R. These dyes may be used alone or in combination of two or more.
【0014】例えば、チアジン系色素およびインジゴ系
色素などのpH指示薬の濃度は特に限定されるものでは
ないが、約100〜約100000ppmの範囲である
ことが好ましい。For example, the concentration of the pH indicator such as thiazine dye and indigo dye is not particularly limited, but it is preferably in the range of about 100 to about 100,000 ppm.
【0015】また、これらは、その酸素の存在の有無に
よる色相の変化をより一層明確なものとするために、酸
素の存在の有無にかかわらず、色相の変化を伴わない通
常の色素、顔料、染料などと併用することもできる。Further, in order to further clarify the change in hue due to the presence or absence of oxygen, these are conventional dyes or pigments that do not cause a change in hue regardless of the presence or absence of oxygen. It can also be used in combination with a dye or the like.
【0016】上記チアジン系色素および/またはインジ
ゴ系色素などのpH指示薬と前記システイン類またはシ
スチン類などの還元性物質との使用割合は、特に限定さ
れるものではないが、通常システイン類またはシスチン
類などの還元性物質100重量部に対して、チアジン系
色素および/またはインジゴ系色素などのpH指示薬が
約1/1000〜約1000重量部、好ましくは約1/
10〜約10重量部の範囲がよい。なお、還元性物質と
pH指示薬の組み合わせとしては、好ましくは、還元性
物質としてシステインまたはその塩(特に塩酸塩)を、
pH指示薬としてメチレンブルーを使用する。The ratio of the pH indicator such as the thiazine dye and / or indigo dye to the reducing substance such as cysteine or cystine is not particularly limited, but is usually cysteine or cystine. PH indicator such as thiazine dye and / or indigo dye to about 100 parts by weight of a reducing substance such as 1 to 1000 parts by weight, preferably about 1 to 1000 parts by weight.
A range of 10 to about 10 parts by weight is preferred. As the combination of the reducing substance and the pH indicator, cysteine or a salt thereof (especially hydrochloride) is preferably used as the reducing substance,
Methylene blue is used as a pH indicator.
【0017】溶媒としては、本発明のインキ組成物の各
成分を均一にかつ安定に溶解または分散することのでき
るものであることが好ましく、例えばトルエン、キシレ
ンなどの芳香族炭化水素、シクロヘキサンなどの脂肪族
炭化水素、酢酸エチル、酢酸ブチルなどのエステル類、
メタノール、エタノールなどのアルコール類、水および
これらの混合物などが挙げられる。特に、水およびアル
コール類のうち少なくとも1種であることが好ましい。The solvent is preferably one which can uniformly or stably dissolve or disperse each component of the ink composition of the present invention. For example, aromatic hydrocarbons such as toluene and xylene, cyclohexane and the like. Esters such as aliphatic hydrocarbons, ethyl acetate, butyl acetate,
Examples thereof include alcohols such as methanol and ethanol, water and a mixture thereof. In particular, at least one of water and alcohols is preferable.
【0018】結合剤は、還元性物質、pH指示薬などを
支持体上に固着するために使用されるもので、このよう
な結合剤としては、例えばポリアクリル酸、ポリビニル
アルコール、ポリビニルブチラール、ポリビニルアセタ
ール、ポリ酢酸ビニル、ポリウレタン、酢酸ビニル部分
ケン化物などが挙げられる。The binder is used for fixing a reducing substance, a pH indicator and the like on a support, and examples of such a binder include polyacrylic acid, polyvinyl alcohol, polyvinyl butyral and polyvinyl acetal. , Polyvinyl acetate, polyurethane, partially saponified vinyl acetate, and the like.
【0019】インキ組成物は、上記還元性物質、pH指
示薬、溶媒、結合剤の他に、さらに適当なアルカリ化剤
や賦形剤などを任意に添加配合することができる。In addition to the above reducing substance, pH indicator, solvent and binder, the ink composition may further contain an appropriate alkalizing agent, excipient or the like.
【0020】ここでアルカリ化剤としては、システイン
類、シスチン類などの還元性物質の酸化を促進するも
の、酸素吸収を促進するものとして機能し、インキ組成
物の系をアルカリ性にすることのできるものであればい
ずれも用いることができる。例えば、アルカリ金属また
はアルカリ土類金属の水酸化物、炭酸塩、炭酸水素塩、
リン酸塩、ホウ酸塩などの水溶性化合物などが挙げられ
る。これらは含水物でもよいし、また、無水物でもよ
い。例えば、ホウ酸ナトリウム、水酸化ナトリウム、炭
酸ナトリウム、炭酸水素ナトリウム、水酸化リチウム、
リン酸カルシウム、水酸化バリウム、水酸化マグネシウ
ム、リン酸カルシウムなどが挙げられる。これらの中で
も、ホウ酸ナトリウム、水酸化ナトリウム、炭酸ナトリ
ウムなどが好ましい。これらはその一種を単独で用いて
もよく、また、二種以上を併用することもできる。な
お、アルカリ化剤を添加する場合には、インキ組成物中
のpH指示薬の色調変化反応が促進され、鮮やかな色調
が発現され、酸素の存在の有無をより確実に検知できる
場合がある。Here, the alkalizing agent functions as an agent that promotes the oxidation of reducing substances such as cysteine and cystine and an agent that promotes the absorption of oxygen, and can make the system of the ink composition alkaline. Any of these can be used. For example, alkali metal or alkaline earth metal hydroxides, carbonates, hydrogen carbonates,
Examples thereof include water-soluble compounds such as phosphate and borate. These may be hydrous or anhydrous. For example, sodium borate, sodium hydroxide, sodium carbonate, sodium hydrogen carbonate, lithium hydroxide,
Examples thereof include calcium phosphate, barium hydroxide, magnesium hydroxide and calcium phosphate. Among these, sodium borate, sodium hydroxide, sodium carbonate and the like are preferable. These may be used alone or in combination of two or more. When an alkalizing agent is added, the color change reaction of the pH indicator in the ink composition is promoted, a vivid color tone is developed, and the presence or absence of oxygen may be more reliably detected.
【0021】また、賦形剤としては、インキ組成物の取
り得る形態に調製可能な公知の各種のものをいずれも用
いることができる。例えば、ゼオライト、活性白土、珪
酸カルシウム、結晶セルロースなどの反応の場を提供す
るのに役立つものが挙げられる。賦形剤は、酸素インジ
ケーターの色素の変色の目視確認をできるだけ阻害しな
い色調、例えば、無色ないし淡色であることが好まし
い。As the excipient, any of various known excipients that can be prepared in a form that the ink composition can take can be used. For example, zeolites, activated clays, calcium silicates, crystalline celluloses and the like which serve to provide a reaction site. The excipient preferably has a color tone that does not hinder visual confirmation of the discoloration of the dye of the oxygen indicator as much as possible, for example, a colorless or pale color.
【0022】なお、インキ組成物の印刷によって形成さ
れる塗膜は、塗膜自体およびその使用される包装体内に
存在する水分と共に、通常充分に所望の酸素検知能また
はこれと酸素吸収能とを発揮することができるが、その
酸素検知や酸素吸収のための反応に必要な水分が上記包
装体内に不足する場合などにおいては、これを大気中か
ら得るために、塩化カルシウムなどの潮解性を有する物
質をインキ組成物にさらに配合することもできる。The coating film formed by printing the ink composition, together with the water present in the coating film itself and the package in which it is used, usually has a desired oxygen detection ability or a desired oxygen detection ability and oxygen absorption ability. Although it can be exerted, it has a deliquescent property such as calcium chloride in order to obtain it from the atmosphere when the water necessary for the oxygen detection or reaction for oxygen absorption is insufficient in the package. Substances can also be further incorporated into the ink composition.
【0023】上記還元性物質、pH指示薬、結合剤など
を溶媒に溶解もしくは分散させる方法としては上記全成
分を混合してサンドミル、ボールミル、ロールミル、ア
トライターなどの一般的混合、分散手段により練肉すれ
ばよい。溶解または分散により、インキ組成物は還元性
物質、pH指示薬を含む水溶液または有機溶媒溶液を均
一に含有するインキ組成物となる。To dissolve or disperse the reducing substance, the pH indicator, the binder and the like in a solvent, all the above components are mixed and the mixture is kneaded by a general mixing and dispersing means such as a sand mill, a ball mill, a roll mill or an attritor. do it. By dissolving or dispersing, the ink composition becomes an ink composition that uniformly contains a reducing substance, an aqueous solution containing a pH indicator, or an organic solvent solution.
【0024】支持体上にインキ組成物を塗布する方法と
しては、印刷法、例えば、スクリーン印刷法、凹版印刷
法、凸版印刷法、グラビア印刷法、フレキソ印刷法およ
びオフセット印刷法などや、コーティング法、例えば、
ロールコーティング、スプレーコーティング、ディップ
コーティングおよびベタコーティングなどが挙げられる
が、好ましくは、印刷法を用いる。インキ組成物を例え
ばガス非透過性包装材などである支持体に印刷し、酸素
検知部を作製することができる。例えば、支持体に酸素
検知部を連続して印刷し、ヒートシールおよび切断する
ことにより包装袋を加工する場合には、支持体が巻き取
り供給され得ることから、グラビア印刷やフレキソ印刷
が適している。The method of applying the ink composition onto the support is a printing method, for example, a screen printing method, an intaglio printing method, a letterpress printing method, a gravure printing method, a flexographic printing method and an offset printing method, and a coating method. , For example,
Roll coating, spray coating, dip coating, solid coating and the like can be mentioned, but a printing method is preferably used. The ink composition can be printed on a support which is, for example, a gas-impermeable packaging material to prepare an oxygen detection part. For example, when the packaging is processed by continuously printing the oxygen detection unit on the support and then heat-sealing and cutting the support, the support may be wound and supplied, and thus gravure printing or flexographic printing is suitable. There is.
【0025】支持体としては、インキ組成物と反応せ
ず、試薬の呈色性を阻害しない物であることが好まし
い。例えば、紙、合成紙、不織布、または合成樹脂フィ
ルムなどを目的、使用形態に合わせて用いることができ
る。また、酸素検知部は、文字、絵柄などのパターンを
有するインキ層からなることが好ましい。特に酸素検知
部の形状として文字を選択した場合、商品名、成分名、
使用説明などの表示とすることもできる。さらに酸素検
知部を見やすくするために支持体を適宜着色することも
できる。The support is preferably one which does not react with the ink composition and does not impair the color developability of the reagent. For example, paper, synthetic paper, non-woven fabric, synthetic resin film, or the like can be used depending on the purpose and usage. Further, it is preferable that the oxygen detecting section is composed of an ink layer having a pattern such as letters and pictures. Especially when you select letters as the shape of the oxygen detector, the product name, ingredient name,
It is also possible to display the usage instructions. Further, the support can be appropriately colored to make the oxygen detection part easier to see.
【0026】酸素インジケーター機能付き包装体は、好
ましくは、医薬、薬品、食品(飲料を含む)などの内容
物を収容するガス透過性材料からなる容器をガス非透過
性包装材で包装し、該包装体内を脱酸素雰囲気にすると
共に包装体内に酸素検知部を配置することにより製造す
ることができる。酸素検知部は、ガス透過性容器の外
面、ガス透過性容器とガス非透過性包装材の間の空間
部、およびガス非透過性包装材の内面に設けることがで
きる。ガス透過性容器の外面またはガス非透過性包装材
の内面に酸素検知部を配置する方法としては、インキ組
成物の印刷によって作製した酸素検知部をこれらの面に
接着する方法、あるいはインキ組成物を直接これらの面
に印刷する方法がある。好ましくは、直接これら容器ま
たは包装材の面に印刷する。なお、ガス透過性容器その
ものを支持体とし、ガス透過性容器の外面にインキ組成
物を塗布し、ガス透過性容器そのものを酸素検知部とし
て使用することもできる。また、ガス非透過性包装材そ
のものを支持体とし、ガス非透過性包装材の内面にイン
キ組成物を塗布し、ガス非透過性包装材そのものを酸素
検知部として使用することもできる。ガス透過性容器の
外面またはガス非透過性包装材の内面にインキ組成物を
直接印刷する場合は、ガス透過性容器の外面またはガス
非透過性包装材の内面にインキ組成物を印刷後、印刷面
をガス透過性フィルムで覆うことも可能であり、皮覆し
た場合は内容物または容器との接触がなく、衛生的であ
りかつ指示部の摩耗も防ぐことができるので好適であ
る。ここで用いられるガス透過性フィルムとしては、例
えば、低密度ポリエチレン、直鎖状低密度ポリエチレ
ン、ポリプロピレン、アイオノマー、エチレン−酢酸ビ
ニル共重合体などが挙げられる。The oxygen indicator packaging is preferably a container made of a gas permeable material for containing contents such as medicines, medicines, foods (including beverages), which is packaged with a gas impermeable packaging material. It can be manufactured by setting a deoxygenated atmosphere in the package and arranging an oxygen detector in the package. The oxygen detector can be provided on the outer surface of the gas permeable container, the space between the gas permeable container and the gas impermeable packaging material, and the inner surface of the gas impermeable packaging material. As a method of arranging the oxygen detection part on the outer surface of the gas permeable container or the inner surface of the gas impermeable packaging material, a method of adhering the oxygen detection part prepared by printing the ink composition to these surfaces, or an ink composition Can be printed directly on these surfaces. Preferably, printing is performed directly on the surface of these containers or packaging materials. The gas permeable container itself may be used as a support, the ink composition may be applied to the outer surface of the gas permeable container, and the gas permeable container itself may be used as the oxygen detector. It is also possible to use the gas-impermeable packaging material itself as a support, apply the ink composition to the inner surface of the gas-impermeable packaging material, and use the gas-impermeable packaging material itself as the oxygen detector. When directly printing the ink composition on the outer surface of the gas-permeable container or the inner surface of the gas-impermeable packaging material, after printing the ink composition on the outer surface of the gas-permeable container or the inner surface of the gas-impermeable packaging material, printing It is also possible to cover the surface with a gas permeable film, and when covered with a skin, there is no contact with the contents or the container, it is hygienic and wear of the indicator can be prevented, which is preferable. Examples of the gas permeable film used here include low density polyethylene, linear low density polyethylene, polypropylene, ionomer, and ethylene-vinyl acetate copolymer.
【0027】内容物としては、酸素と接触して変質しや
すい医薬、薬品、食品(飲料を含む)など、または、品
質の劣化、薬効が失われるおそれのある医薬、薬品、食
品(飲料を含む)などが挙げられる。これら医薬、薬
品、食品(飲料を含む)などとしては、特に限定される
ものではない。医薬、薬品としては、例えば、アミノ酸
薬液、糖質薬液、ビタミン含有薬液、重炭酸塩薬液、脂
肪乳剤、および抗生物質製剤などが挙げられる。アミノ
酸薬液としては、例えば、必須アミノ酸などを含有する
アミノ酸輸液、グリチルリチン製剤などが、糖質薬液と
しては、例えば、還元糖などを含有する糖輸液などが、
ビタミン含有薬液としては、例えば、混合ビタミン剤な
どが、重炭酸塩薬液としては、例えば、人工腎臓用透析
液、灌流液及び補充液、腹膜透析液、歯科用根管拡大
剤、人工髄液、臓器保存剤、眼内灌流液、心臓灌流液、
心筋保護液、腹腔洗浄液、解毒剤などが、脂肪乳剤とし
ては、例えば、植物油乳剤などが挙げられる。食品(飲
料を含む)としては、例えば、お茶、コーヒー、チー
ズ、ハム、味噌および生肉などを挙げることができる。The contents include medicines, medicines, foods (including beverages) that are easily deteriorated by contact with oxygen, or medicines, medicines, foods (including beverages) that may deteriorate in quality or lose their medicinal effects. ) And the like. These medicines, medicines, foods (including beverages), etc. are not particularly limited. Examples of the medicines and drugs include amino acid drug solutions, sugar drug solutions, vitamin-containing drug solutions, bicarbonate drug solutions, fat emulsions, and antibiotic preparations. Examples of the amino acid drug solution include amino acid infusions containing essential amino acids and the like, glycyrrhizin preparations, and examples of the sugar drug solution include sugar infusion solutions containing reducing sugars and the like,
Examples of the vitamin-containing drug solution include mixed vitamin preparations, and examples of the bicarbonate drug solution include artificial kidney dialysate, perfusate and replenisher, peritoneal dialysate, dental root canal expander, artificial cerebrospinal fluid, Organ preservative, intraocular perfusate, cardiac perfusate,
Examples of the fat emulsion include cardioplegic solution, peritoneal lavage fluid, antidote, and the like, and vegetable oil emulsion and the like. Examples of foods (including beverages) include tea, coffee, cheese, ham, miso, and raw meat.
【0028】医薬、薬品、食品(飲料を含む)などを収
容あるいは充填するためのガス透過性容器としては、従
来より当該技術分野で用いられているものを用いること
ができる。好ましくは、ガス透過性プラスチック容器を
用いる。例えば、ポリエチレン製、エチレン酢酸ビニル
共重合体製、ポリプロピレン製、ポリエチレン製のもの
やこれらを適当な比率で配合またはラミネートしたもの
などが挙げられる。これら容器の形状、大きさなどには
特に制限はない。例えば、長方形や円筒形のものが挙げ
られる。また、それらの内容量は特に限定されるもので
はないが、好ましくは約2mL〜約3L程度の範囲の容
器を用いる。As the gas permeable container for containing or filling medicines, medicines, foods (including beverages) and the like, those conventionally used in the technical field can be used. Preferably, a gas permeable plastic container is used. Examples thereof include those made of polyethylene, ethylene vinyl acetate copolymer, polypropylene, polyethylene, and those prepared by mixing or laminating these at an appropriate ratio. The shape and size of these containers are not particularly limited. For example, a rectangular shape or a cylindrical shape can be used. Further, the content volume thereof is not particularly limited, but a container having a range of about 2 mL to about 3 L is preferably used.
【0029】本発明におけるガス非透過性包装材におけ
る「ガス非透過性」とは、必ずしも厳密にガスを透過し
ないという意味ではなく、そのガス非透過性が上記ガス
透過性容器のそれよりも大きいことを意味しており、こ
れは上記容器と同一の材質でもその厚みが大きい場合に
は、本発明にいうガス非透過性包装材として利用するこ
とができる。かかるガス非透過性包装材の材質として
は、特に制限されるものではなく、好ましくは、通常か
かる包装材として汎用されている、例えば、ポリエチレ
ンテレフタレート(PET)、ポリエチレンナフタレー
ト(PEN)、ポリビニルアルコール(PVA)、エチ
レンビニルアルコール共重合体(EVOH)、ポリ塩化
ビニリデン(PVDC)、ナイロンなどの材質のもの
や、これらの表面にさらに酸化珪素、酸化アルミニウム
などの無機物を蒸着させたものや、これら各種材質の多
層フィルム(ラミネートフィルム)からなるものなどが
挙げられる。これらガス非透過性包装材の形状、大きさ
などは上記ガス透過性容器を収容できれば特に制限され
るものではない。好ましくは、ガス透過性容器の約1.
2〜約3倍容量程度の大きさであるのがよい。The term "gas impermeable" in the gas impermeable packaging material of the present invention does not necessarily mean that gas is not exactly permeable, but its gas impermeable property is larger than that of the gas permeable container. This means that even if the same material as the above-mentioned container has a large thickness, it can be used as the gas impermeable packaging material in the present invention. The material of such a gas-impermeable packaging material is not particularly limited, and is preferably generally used as such a packaging material, for example, polyethylene terephthalate (PET), polyethylene naphthalate (PEN), polyvinyl alcohol. (PVA), ethylene vinyl alcohol copolymer (EVOH), polyvinylidene chloride (PVDC), nylon, and other materials, those on which inorganic materials such as silicon oxide and aluminum oxide are further deposited, and these Examples thereof include those made of multi-layer films (laminate films) of various materials. The shape and size of these gas-impermeable packaging materials are not particularly limited as long as the gas-permeable container can be housed therein. Preferably about 1.
The size is preferably about 2 to about 3 times the volume.
【0030】本発明によってガス非透過性包装材からな
る包装体の不具合を容易に検出することができる。不具
合には、例えば、ピンホール、シール不良などの発生に
よるガス雰囲気の変化が含まれる。より具体的には、ガ
ス非透過性包装材からなる包装体のピンホール発生など
に起因する包装体内への酸素の侵入、包装体の密閉不良
などによる空気漏れ、脱気の不完全さなどが含まれる。According to the present invention, it is possible to easily detect a defect in a package made of a gas impermeable packaging material. Defects include, for example, changes in the gas atmosphere due to pinholes, poor seals, and the like. More specifically, the intrusion of oxygen into the package due to the occurrence of pinholes in the package made of gas impermeable packaging, air leakage due to poor sealing of the package, incomplete deaeration, etc. included.
【0031】ガス透過性容器をガス非透過性包装材で包
装した包装体を脱酸素雰囲気とするための手段として
は、ガス置換法、真空包装法、脱酸素剤法などが挙げら
れる。ガス置換法としては、例えば、窒素ガス、炭酸ガ
ス、または炭酸ガスと窒素ガスとの混合ガスなどの炭酸
ガスを含有する混合ガスなどを包装体内に封入する方法
などが挙げられる。真空包装法としては、例えば、真空
包装機を用いる方法が挙げられる。真空包装機として
は、当該技術分野で汎用されているものを用いることが
できる。脱酸素剤法としては、例えば、脱酸素剤を用い
る方法が挙げられる。脱酸素剤としては、エージレス
(三菱ガス化学(株)製)などを用いることができる。
本発明の包装体は、上記より自明であるが自体公知の方
法により製造される。好ましくは、酸素で変質しやすい
医薬または食品(飲料を含む)をガス透過性容器に収容
し、これをさらにガス非透過性包装材にて包装し、ガス
非透過性包装体内を脱酸素雰囲気として、支持体上にイ
ンキ組成物を印刷することによって酸素検知部を設ける
ことにより製造される。なお、還元性物質としてシステ
イン類またはシスチン類を用いるときは、これらが脱酸
素剤としての役割も果たすため、特に脱酸素剤を用いる
必要はなくてもよい。Examples of means for putting a package in which a gas permeable container is packaged in a gas impermeable packaging material into a deoxidizing atmosphere include a gas replacement method, a vacuum packaging method, and an oxygen scavenging method. Examples of the gas replacement method include a method of enclosing a mixed gas containing carbon dioxide gas such as nitrogen gas, carbon dioxide gas, or a mixed gas of carbon dioxide gas and nitrogen gas in a package. Examples of the vacuum packaging method include a method using a vacuum packaging machine. As the vacuum packaging machine, one generally used in the technical field can be used. Examples of the oxygen scavenger method include a method using a oxygen scavenger. As the oxygen scavenger, Ageless (manufactured by Mitsubishi Gas Chemical Co., Inc.) or the like can be used.
The package of the present invention is manufactured by a method known per se, which is obvious from the above. Preferably, a drug or food (including beverage) that is easily deteriorated by oxygen is contained in a gas permeable container, which is further packaged with a gas impermeable packaging material to create a deoxygenated atmosphere in the gas impermeable packaging. It is manufactured by printing an ink composition on a support to provide an oxygen detector. When cysteines or cystines are used as the reducing substance, they also serve as an oxygen scavenger, so it is not necessary to use an oxygen scavenger.
【0032】[0032]
【実施例】以下、本発明の実施例および試験例を説明す
るが、以下の実施例および試験例は本発明の好ましい実
施態様にすぎず、本発明の技術的範囲を何等限定するも
のではない。EXAMPLES Examples and test examples of the present invention will be described below, but the following examples and test examples are merely preferred embodiments of the present invention and do not limit the technical scope of the present invention. .
【0033】
実施例1
L−システイン塩酸塩 (和光純薬) 6.0g
メチレンブルー(和光純薬) 4.0g
イソプロピルアルコール(大阪プリンティング・インキ) 33.0g
水 100.0g
上記成分を混合して得た溶液を、ポリビニルアルコール
(JIP41C)50重量部に対して、1重量部混入
し、さらに紫外線吸収剤を含む黄色インキ(東洋インキ
社製WSイエロー2RN−1T)5重量部を加えた。サ
ンドミル機にて1時間練肉することにより水溶性バイン
ダー樹脂を用いたインキ組成物を得た。酸素透過度1m
l/m2/24hr/atm以下である酸素非透過性包
装材のPVAフィルムにグラビア印刷法により酸素検知
用インキ組成物を印刷し、印刷面にLLDPEフィルム
をラミネートしシーラント層とした。また、表層面にP
ETフィルムをラミネートし、酸素検知部を印刷により
備えているガス非透過性包装材を得た。Example 1 L-Cysteine hydrochloride (Wako Pure Chemical Industries, Ltd.) 6.0 g Methylene blue (Wako Pure Chemical Industries, Ltd.) 4.0 g Isopropyl alcohol (Osaka Printing Ink Co., Ltd.) 33.0 g Water 100.0 g Obtained by mixing the above components. 1 part by weight of the solution was mixed with 50 parts by weight of polyvinyl alcohol (JIP41C), and 5 parts by weight of a yellow ink (WS Yellow 2RN-1T manufactured by Toyo Ink Co., Ltd.) containing an ultraviolet absorber was added. The ink composition using the water-soluble binder resin was obtained by kneading the meat for 1 hour with a sand mill. Oxygen permeability 1m
The oxygen detecting ink composition was printed by a gravure printing method PVA film l / m 2 / 24hr / atm or less is oxygen-impermeable packaging material, laminated with LLDPE film on the printing surface and sealant layer. Also, P on the surface
An ET film was laminated, and a gas impermeable packaging material having an oxygen detection portion by printing was obtained.
【0034】内容物として、下記に示す組成のアミノ酸
輸液500mLを収容したポリエチレン製容器を、前記
で調製した包装材で、酸素検知部を有する面を内側にし
て包装し、容器と包装材との空間部(容積約100m
L)を窒素ガス置換後、脱酸素剤エージレス(ZH−1
00P)を入れ包装材を密封して、本発明の酸素インジ
ケーター機能付き包装体を得た。
アミノ酸輸液
L−ロイシン 7.0g、L−イソロイシン 4.0
g、L−バリン 4.0g、酢酸L−リジン 7.4
g、L−トレオニン 2.85g、L−トリプトファン
1.0g、L−メチオニン 1.95g、L−フェニ
ルアラニン 3.5g、L−システイン 0.5g、L
−チロシン 0.25g、L−アルギニン5.25g、
L−ヒスチジン 2.5g、L−アラニン 4.0g、
L−プロリン 2.5g、L−セリン 1.5g、アミ
ノ酢酸 2.95g、L−アスパラギン酸 0.5g、
L−グルタミン酸 0.5gおよび氷酢酸 1.45g
を蒸留水に溶解して500mL溶液を得た。As a content, a polyethylene container containing 500 mL of an amino acid infusion solution having the composition shown below was packaged with the packaging material prepared as described above with the surface having the oxygen detecting portion facing inward. Space (volume approx. 100 m
L) is replaced with nitrogen gas, and then the oxygen scavenger ageless (ZH-1
00P) and the packaging material was sealed to obtain the packaging body with the oxygen indicator function of the present invention. Amino acid infusion L-leucine 7.0 g, L-isoleucine 4.0
g, L-valine 4.0 g, L-lysine acetate 7.4
g, L-threonine 2.85 g, L-tryptophan 1.0 g, L-methionine 1.95 g, L-phenylalanine 3.5 g, L-cysteine 0.5 g, L
-Tyrosine 0.25 g, L-arginine 5.25 g,
L-histidine 2.5 g, L-alanine 4.0 g,
L-proline 2.5 g, L-serine 1.5 g, aminoacetic acid 2.95 g, L-aspartic acid 0.5 g,
L-glutamic acid 0.5 g and glacial acetic acid 1.45 g
Was dissolved in distilled water to obtain a 500 mL solution.
【0035】密封後24時間で、空間部が無酸素状態と
なり、このことは、密封直後、青色であった酸素検知部
が、密封24時間後に黄色に変色したことから確認され
た。Twenty-four hours after the sealing, the space became anoxic, which was confirmed by the fact that the oxygen detection portion, which was blue immediately after sealing, turned yellow after sealing for 24 hours.
【0036】比較例1
ガス非透過性包装材であるPVAフィルムにLDPEフ
ィルムをラミネートしシーラント層とし、表層面にPE
Tフィルムをラミネートしガス非透過性包装材を得た。
酸素インジケーターとして三菱ガス化学製 エージレス
アイ タイプ:ペーパーアイ Pアイ−Mを使用した。
上記アミノ酸輸液500mLを収容したポリエチレン製
容器を前記で作製した包装材で包装し、脱酸素剤エージ
レス(ZH−100P)をエージレスアイと共に入れ、
容器と包装材との空間部(容積約100mL)を窒素ガ
ス置換後、無酸素状態として密封し、各条件下に保存し
た。密封後24時間で、空間部が無酸素状態となり、こ
のことは、密封直後、紫色であったエージレスアイが、
密封24時間後にはピンク色に変色したことから確認さ
れた。Comparative Example 1 A PVA film, which is a gas impermeable packaging material, is laminated with an LDPE film to form a sealant layer, and the surface layer surface is PE.
The T film was laminated to obtain a gas impermeable packaging material.
As an oxygen indicator, Mitsubishi Gas Chemical's Ageless Eye Type: Paper Eye P Eye-M was used.
A polyethylene container containing 500 mL of the amino acid infusion is packed with the packing material prepared above, and an oxygen scavenger AGELESS (ZH-100P) is put together with AGELESS EYE.
The space between the container and the packaging material (volume: about 100 mL) was replaced with nitrogen gas, then sealed in an oxygen-free state, and stored under each condition. Twenty-four hours after sealing, the space became anoxic, which means that the ageless eye, which was purple immediately after sealing,
It was confirmed that the color changed to pink 24 hours after the sealing.
【0037】実施例2
実施例1と全く同様にしてインキ組成物を調製した。こ
れを実施例1と同様にしてアルミナ蒸着PETフィルム
上にスクリーン印刷法により塗布し、70℃で1時間乾
燥して、印刷面にLDPEフィルムをラミネートしシー
ラント層とし、表層面にPETフィルムをラミネートし
酸素検知部を備えたガス非透過性包装材を得た。内容物
として、下記に示したシステインを含むグリチルリチン
製剤20mLを収容したポリエチレン製容器を、前記で
調製した酸素検知部を形成させた包装材で酸素検知部を
有する面を内側にして包装し、脱酸素剤エージレス(Z
H−10P)と共に入れ、容器と包装材との空間部(容
積約30mL)を窒素ガス置換後、包装材を密封して、
本発明の酸素インジケーター機能付き包装体を得た。
グリチルリチン酸製剤
グリチルリチン 40mg、アミノ酢酸 400mgお
よびL−システイン20mgを蒸留水に溶解して20m
L溶液を得た。Example 2 An ink composition was prepared in exactly the same manner as in Example 1. This was applied onto an alumina vapor-deposited PET film by a screen printing method in the same manner as in Example 1, dried at 70 ° C. for 1 hour, the print surface was laminated with an LDPE film to form a sealant layer, and the surface layer surface was laminated with a PET film. Then, a gas-impermeable packaging material having an oxygen detection part was obtained. As a content, a polyethylene container containing 20 mL of a glycyrrhizin preparation containing cysteine shown below was packaged with the surface having the oxygen detection part inside by the packaging material formed with the oxygen detection part prepared above, and removed. Oxygen agent Ageless (Z
H-10P), and replace the space between the container and the packaging material (volume of about 30 mL) with nitrogen gas, and then seal the packaging material.
A package with an oxygen indicator function of the present invention was obtained. Glycyrrhizic acid preparation Glycyrrhizin 40 mg, aminoacetic acid 400 mg and L-cysteine 20 mg were dissolved in distilled water to obtain 20 m.
An L solution was obtained.
【0038】密封後24時間で、空間部が無酸素状態と
なり、このことは、密封直後、青色であった酸素検知部
材が、密封24時間後に黄色に変色したことから確認さ
れた。24 hours after the sealing, the space became anoxic, which was confirmed by the fact that the oxygen detection member, which was blue immediately after the sealing, turned yellow 24 hours after the sealing.
【0039】比較例2
実施例2と同様にグリチルリチン製剤20mLを収容し
たポリエチレン製容器を、酸素検知部材の印刷していな
いアルミナ蒸着PETフィルムからなるガス非透過性包
装材で包装し、エージレスアイを脱酸素剤エージレス
(ZH−10P)とともに入れ、容器と包装材との空間
部(容積約30mL)を窒素置換後、包装材を密封し
て、比較例2とした。密封後24時間で、空間部が無酸
素状態となり、このことは、密封直後、紫色であったエ
ージレスアイが、密封24時間後にピンクに変色したこ
とから確認された。Comparative Example 2 A polyethylene container containing 20 mL of the glycyrrhizin preparation was packaged in the same manner as in Example 2 with a gas impermeable packaging material composed of an alumina vapor-deposited PET film on which an oxygen detection member was not printed to obtain an ageless eye. The oxygen absorber was put together with Ageless (ZH-10P), the space between the container and the packaging material (volume: about 30 mL) was replaced with nitrogen, and then the packaging material was sealed to obtain Comparative Example 2. Twenty-four hours after sealing, the space became anoxic, which was confirmed by the fact that the ageless eye, which was purple immediately after sealing, turned pink after sealing for 24 hours.
【0040】試験例1
実施例1、2および比較例1、2で作製した包装体の包
装材に、注射針(27G、テルモ社製、ネオラス)でピ
ンホール(直径約500μm、短径約50μm)をあ
け、包装体における酸素検知部の色の変色を外部から目
視観察した。結果を下記表に示す。変色時間は、ピンホ
ール後変色反応が終了するまでの時間を表す。Test Example 1 A wrapping material of the wrapping body produced in Examples 1 and 2 and Comparative Examples 1 and 2 was pinhole (diameter about 500 μm, minor axis about 50 μm) with an injection needle (27 G, Terumo, Neorus). ) Was opened and the discoloration of the color of the oxygen detection part in the package was visually observed from the outside. The results are shown in the table below. The color change time represents the time until the color change reaction is completed after the pinhole.
【表1】 [Table 1]
【0041】試験例2
インキ組成物を作製し、光と熱に対する安定性を調査し
た。試験例1と同様にして、アミノ酸輸液500mLを
収容したポリエチレン製容器を実施例1および2で作製
した本発明包装体の包装材で包装し、脱酸素剤エージレ
ス(ZH−100P)を入れ、窒素置換後に密封し、無
酸素状態として各条件下に保存した。比較例として、ペ
ーパーアイとアミノ酸輸液500mLを収容したポリエ
チレン製容器を比較例1および2で作製された包装材で
包装し、脱酸素剤エージレス(ZH−100P)を入
れ、窒素置換後に密封し、無酸素状態として各条件下に
保存した。Test Example 2 An ink composition was prepared and its stability to light and heat was investigated. In the same manner as in Test Example 1, a polyethylene container containing 500 mL of an amino acid infusion solution was wrapped with the packaging material of the packaging body of the present invention produced in Examples 1 and 2, and an oxygen scavenger Ageless (ZH-100P) was added, and nitrogen was added. After the replacement, the container was sealed and kept in an oxygen-free state under each condition. As a comparative example, a polyethylene container containing 500 mL of the paper eye and amino acid infusion solution was wrapped with the packaging material produced in Comparative Examples 1 and 2, and the oxygen scavenger Ageless (ZH-100P) was put therein, and the container was sealed after nitrogen replacement, It was stored under each condition in an anoxic state.
【0042】(1)光安定性試験
太陽光の照射する窓ガラスに張り付けして保存し、色調
の変化を調査した。結果を下記表に示す。(1) Light Stability Test The change in color tone was investigated by sticking and storing on a window glass irradiated with sunlight. The results are shown in the table below.
【表2】 [Table 2]
【0043】比較例1および2では経時3日後に色調が
不安定となったのに対し、実施例1および2では5日後
も無酸素状態の色調の黄色を呈した。14日後にガス非
透過性包装材で包装された包装体を開封すると、実施例
1および2では青色に戻ったが、比較例1および2では
変色しなかった。In Comparative Examples 1 and 2, the color tone became unstable after 3 days, whereas in Examples 1 and 2, the anoxic color tone of yellow was exhibited even after 5 days. When the package wrapped with the gas impermeable packaging material was opened 14 days later, it returned to blue in Examples 1 and 2, but no color change in Comparative Examples 1 and 2.
【0044】(2)安定性試験
40℃、無酸素保存経時で色調の変化を調査した。結果
を下記表に示す。(2) Stability test Changes in color tone were investigated with the passage of time at 40 ° C. under oxygen-free storage. The results are shown in the table below.
【表3】 [Table 3]
【0045】比較例1および2では経時2ヵ月後に無酸
素時に示す色調が不良となったのに対し、実施例1およ
び2では3ヶ月後も無酸素状態の色調の黄色を呈した。
3ヵ月後にガス非透過性包装材で包装された包装体を開
封すると、実施例1および2では青色に戻ったが、比較
例1および2では変色しなかった。In Comparative Examples 1 and 2, the color tone shown in the absence of oxygen was poor after 2 months, whereas in Examples 1 and 2, the oxygen-free color tone was yellow even after 3 months.
When the package wrapped with the gas impermeable packaging material was opened 3 months later, it returned to blue in Examples 1 and 2, but did not discolor in Comparative Examples 1 and 2.
【0046】[0046]
【発明の効果】本発明によれば、外部から酸素検知部の
変色が容易に確認でき、さらに、光安定性および変色速
度の優れた酸素インジケーター機能付き包装体を得るこ
とができる。EFFECTS OF THE INVENTION According to the present invention, it is possible to easily confirm the discoloration of the oxygen detection portion from the outside, and further to obtain a package with an oxygen indicator function which is excellent in light stability and discoloration speed.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 湯山 恒平 徳島県板野郡松茂町広島字北ハリ20−1 Fターム(参考) 2G042 AA01 BB09 CA01 CB01 DA03 DA08 FA05 FA12 FB07 FC03 FC07 GA04 HA01 HA10 2G054 AA01 AB10 CA08 EA06 GB04 GE10 3E067 AB01 AB81 BB14C CA06 EA06 EE02 FA04 FC01 GB13 GD01 GD02 GD10 ─────────────────────────────────────────────────── ─── Continued front page (72) Inventor Kohei Yuyama 20-1 Kitahari, Hiroshima, Matsushige-cho, Itano-gun, Tokushima Prefecture F-term (reference) 2G042 AA01 BB09 CA01 CB01 DA03 DA08 FA05 FA12 FB07 FC03 FC07 GA04 HA01 HA10 2G054 AA01 AB10 CA08 EA06 GB04 GE10 3E067 AB01 AB81 BB14C CA06 EA06 EE02 FA04 FC01 GB13 GD01 GD02 GD10
Claims (14)
容したガス透過性容器を、ガス非透過性包装材にて包装
してなり、かつ、包装体内がガス置換、真空、または脱
酸素剤によって脱酸素雰囲気となっている包装体におい
て、上記包装材の不具合による包装体のガス雰囲気変化
を色調変化で検知する酸素検知部を印刷によって備えて
いることを特徴とする酸素インジケーター機能付き包装
体。1. A gas-permeable container containing a drug or food that is easily deteriorated by oxygen is packaged with a gas-impermeable packaging material, and the inside of the package is replaced by gas replacement, vacuum, or an oxygen scavenger. A package with an oxygen indicator function, characterized in that a package having an oxygen-free atmosphere is provided with an oxygen detection unit for detecting a change in the gas atmosphere of the package due to a malfunction of the packaging material by a color tone change by printing.
ミノ酸薬液、糖質薬液、ビタミン含有薬液、重炭酸塩薬
液、脂肪乳剤、および抗生物質製剤からなる群から選択
される一種または二種以上であることを特徴とする請求
項1に記載の酸素インジケーター機能付き包装体。2. A drug or food which is easily altered by oxygen is one or more selected from the group consisting of amino acid drug solutions, sugar drug solutions, vitamin-containing drug solutions, bicarbonate drug solutions, fat emulsions, and antibiotic preparations. The packaging body with an oxygen indicator function according to claim 1, wherein the packaging body has an oxygen indicator function.
リチルリチン製剤であることを特徴とする請求項1また
は2に記載の酸素インジケーター機能付き包装体。3. The packaging body with an oxygen indicator function according to claim 1, wherein the drug or food that is easily deteriorated by oxygen is a glycyrrhizin preparation.
薬を含む水溶液または有機溶媒溶液を含有するインキ組
成物によって形成される塗膜であることを特徴とする請
求項1から3のいずれかに記載の酸素インジケーター機
能付き包装体。4. The coating film formed by an ink composition containing an aqueous solution containing a reducing substance and a pH indicator or an organic solvent solution, as the oxygen detecting part. Package with oxygen indicator function described.
ビタミン類または還元糖類であることを特徴とする請求
項4に記載の酸素インジケーター機能付き包装体。5. The packaging body with an oxygen indicator function according to claim 4, wherein the reducing substance is a reducing amino acid, a reducing vitamin, or a reducing saccharide.
ン類であり、pH指示薬がチアジン系色素および/また
はインジゴ系色素であることを特徴とする請求項4また
は5に記載の酸素インジケーター機能付き包装体。6. The package with an oxygen indicator function according to claim 4, wherein the reducing substance is cysteine or cystine, and the pH indicator is a thiazine dye and / or an indigo dye. .
100〜100000ppmであることを特徴とする請
求項6に記載の酸素インジケーター機能付き包装体。7. The package with an oxygen indicator function according to claim 6, wherein the concentration of cysteine or cystine is 100 to 100,000 ppm.
ステイン、L−システイン塩酸塩、DL−システイン、
DL−システイン塩酸塩、D−システイン、D−システ
イン塩酸塩、塩酸L−エチルシステイン、塩酸L−メチ
ルシステイン、アセチルシステイン、S−カルボキシメ
チル−L−システイン、L−シスチンからなる群から選
択される一種または二種以上であることを特徴とする請
求項6または7に記載の酸素インジケーター機能付き包
装体。8. The cysteines or cystines are L-cysteine, L-cysteine hydrochloride, DL-cysteine,
Selected from the group consisting of DL-cysteine hydrochloride, D-cysteine, D-cysteine hydrochloride, L-ethylcysteine hydrochloride, L-methylcysteine hydrochloride, acetylcysteine, S-carboxymethyl-L-cysteine, L-cystine. One or two or more types, The package with an oxygen indicator function of Claim 6 or 7 characterized by the above-mentioned.
系色素の濃度が100〜100000ppmであること
を特徴とする請求項6に記載の酸素インジケーター機能
付き包装体。9. The package with an oxygen indicator function according to claim 6, wherein the concentration of the thiazine dye and / or the indigo dye is 100 to 100000 ppm.
がウルトラバイオレット、アズレC、アズレB、メチレ
ンブルー、メチオニンブルー、ニューメチレンブルー、
メチレングリーン、ラウスバイオレット、ネオメチレン
ブルー、ブリリアントアリザリンブルー、インジゴ、イ
ンジゴカルミン、ブロムインジゴRからなる群から選択
される一種または二種以上であることを特徴とする請求
項6または9に記載の酸素インジケーター機能付き包装
体。10. The thiazine-based dye or the indigo-based dye is ultra violet, Azure C, Azure B, methylene blue, methionine blue, new methylene blue,
The oxygen indicator according to claim 6 or 9, wherein the oxygen indicator is one or more selected from the group consisting of methylene green, rous violet, neomethylene blue, brilliant alizarin blue, indigo, indigo carmine, and bromindigo R. Functional packaging.
ス非透過性包装材の内面に表示されていることを特徴と
する請求項1から10のいずれかに記載の酸素インジケ
ーター機能付き包装体。11. The packaging body with an oxygen indicator function according to claim 1, wherein the printing is displayed on the outer surface of the gas permeable container or the inner surface of the gas impermeable packaging material.
ことを特徴とする請求項1から11のいずれかに記載の
酸素インジケーター機能付き包装体。12. The package with an oxygen indicator function according to claim 1, wherein the oxygen detector is a pinhole detector.
酸素インジケーター機能付き包装体のガス透過性容器に
収納されている酸素で変質しやすい医薬または食品。13. A medicine or food which is easily deteriorated by oxygen contained in the gas permeable container of the package with an oxygen indicator function according to any one of claims 1 to 12.
請求項1から12のいずれかに記載の酸素インジケータ
ー機能付き包装体のガス透過性容器に収納し、保存する
ことを特徴とする酸素で変質しやすい医薬または食品の
保存方法。14. A medicine or food which is easily deteriorated by oxygen is stored in the gas-permeable container of the package with an oxygen indicator function according to any one of claims 1 to 12, and is preserved, thereby being deteriorated by oxygen. A method of storing medicines or foods that is easy to do.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002143890A JP4018930B2 (en) | 2002-05-17 | 2002-05-17 | Package with oxygen indicator function |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002143890A JP4018930B2 (en) | 2002-05-17 | 2002-05-17 | Package with oxygen indicator function |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2003335380A true JP2003335380A (en) | 2003-11-25 |
JP4018930B2 JP4018930B2 (en) | 2007-12-05 |
Family
ID=29703711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002143890A Expired - Lifetime JP4018930B2 (en) | 2002-05-17 | 2002-05-17 | Package with oxygen indicator function |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4018930B2 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005235485A (en) * | 2004-02-18 | 2005-09-02 | Matsushita Electric Ind Co Ltd | Button type air zinc battery |
WO2007015523A1 (en) * | 2005-08-04 | 2007-02-08 | Torishige Sangyo Co., Ltd. | Humidity sensor |
JP2007074971A (en) * | 2005-09-14 | 2007-03-29 | Aichi Shokai:Kk | Oxidative gas indication material and packing vessel with indication means |
JP2008545968A (en) * | 2005-06-02 | 2008-12-18 | グラクソ グループ リミテッド | Inductive drive type remote oxygen sensor |
US7534615B2 (en) | 2004-12-03 | 2009-05-19 | Cryovac, Inc. | Process for detecting leaks in sealed packages |
WO2009157348A1 (en) * | 2008-06-26 | 2009-12-30 | 大日本住友製薬株式会社 | Method for storage of ammonium dithiocarbamate |
JP2011095020A (en) * | 2009-10-28 | 2011-05-12 | Powdertech Co Ltd | Oxygen detecting agent and method of manufacturing oxygen detecting agent |
JP2014148100A (en) * | 2013-02-01 | 2014-08-21 | Mitsubishi Gas Chemical Co Inc | Method for preserving container filled with liquid chemical |
WO2018207257A1 (en) * | 2017-05-09 | 2018-11-15 | 大塚製薬株式会社 | Packaged medicine |
CN112659693A (en) * | 2020-12-08 | 2021-04-16 | 杭州电子科技大学 | Color sensor for indicating milk deterioration and preparation method thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6063465A (en) * | 1983-09-16 | 1985-04-11 | Dainippon Printing Co Ltd | Oxygen-detecting material |
JPS6063464A (en) * | 1983-09-16 | 1985-04-11 | Dainippon Printing Co Ltd | Oxygen-detecting material |
JPS6063463A (en) * | 1983-09-16 | 1985-04-11 | Dainippon Printing Co Ltd | Oxygen-detecting material |
JPS60181653A (en) * | 1984-02-29 | 1985-09-17 | Dainippon Printing Co Ltd | Oxygen detector |
JPH0634619A (en) * | 1992-07-15 | 1994-02-10 | Nippon Kayaku Co Ltd | Oxygen detecting sheet |
JP2001124759A (en) * | 1999-10-28 | 2001-05-11 | Toppan Printing Co Ltd | Indicator for detecting gas |
JP2002065808A (en) * | 2000-08-30 | 2002-03-05 | Nisshin Seiyaku Kk | Package for stably preserving plastic vessel holding medical solution containing amino acid |
-
2002
- 2002-05-17 JP JP2002143890A patent/JP4018930B2/en not_active Expired - Lifetime
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6063465A (en) * | 1983-09-16 | 1985-04-11 | Dainippon Printing Co Ltd | Oxygen-detecting material |
JPS6063464A (en) * | 1983-09-16 | 1985-04-11 | Dainippon Printing Co Ltd | Oxygen-detecting material |
JPS6063463A (en) * | 1983-09-16 | 1985-04-11 | Dainippon Printing Co Ltd | Oxygen-detecting material |
JPS60181653A (en) * | 1984-02-29 | 1985-09-17 | Dainippon Printing Co Ltd | Oxygen detector |
JPH0634619A (en) * | 1992-07-15 | 1994-02-10 | Nippon Kayaku Co Ltd | Oxygen detecting sheet |
JP2001124759A (en) * | 1999-10-28 | 2001-05-11 | Toppan Printing Co Ltd | Indicator for detecting gas |
JP2002065808A (en) * | 2000-08-30 | 2002-03-05 | Nisshin Seiyaku Kk | Package for stably preserving plastic vessel holding medical solution containing amino acid |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005235485A (en) * | 2004-02-18 | 2005-09-02 | Matsushita Electric Ind Co Ltd | Button type air zinc battery |
JP4576846B2 (en) * | 2004-02-18 | 2010-11-10 | パナソニック株式会社 | Button-type zinc-air battery |
US7534615B2 (en) | 2004-12-03 | 2009-05-19 | Cryovac, Inc. | Process for detecting leaks in sealed packages |
JP2008545968A (en) * | 2005-06-02 | 2008-12-18 | グラクソ グループ リミテッド | Inductive drive type remote oxygen sensor |
WO2007015523A1 (en) * | 2005-08-04 | 2007-02-08 | Torishige Sangyo Co., Ltd. | Humidity sensor |
JP2007040871A (en) * | 2005-08-04 | 2007-02-15 | Torishige Sangyo Co Ltd | Humidity detection material |
JP4597001B2 (en) * | 2005-08-04 | 2010-12-15 | 株式会社鳥繁産業 | Humidity detection material |
JP2007074971A (en) * | 2005-09-14 | 2007-03-29 | Aichi Shokai:Kk | Oxidative gas indication material and packing vessel with indication means |
WO2009157348A1 (en) * | 2008-06-26 | 2009-12-30 | 大日本住友製薬株式会社 | Method for storage of ammonium dithiocarbamate |
JP2011095020A (en) * | 2009-10-28 | 2011-05-12 | Powdertech Co Ltd | Oxygen detecting agent and method of manufacturing oxygen detecting agent |
JP2014148100A (en) * | 2013-02-01 | 2014-08-21 | Mitsubishi Gas Chemical Co Inc | Method for preserving container filled with liquid chemical |
WO2018207257A1 (en) * | 2017-05-09 | 2018-11-15 | 大塚製薬株式会社 | Packaged medicine |
WO2018207681A1 (en) * | 2017-05-09 | 2018-11-15 | 大塚製薬株式会社 | Packaged medicine |
JPWO2018207681A1 (en) * | 2017-05-09 | 2020-03-12 | 大塚製薬株式会社 | Packaging drugs |
CN110891544A (en) * | 2017-05-09 | 2020-03-17 | 大塚制药株式会社 | Packaged pharmaceutical product |
TWI765034B (en) * | 2017-05-09 | 2022-05-21 | 日商大塚製藥股份有限公司 | Packaged medicine |
JP7244415B2 (en) | 2017-05-09 | 2023-03-22 | 大塚製薬株式会社 | packaging medicine |
AU2018264400B2 (en) * | 2017-05-09 | 2023-12-07 | Otsuka Pharmaceutical Co., Ltd. | Packaged medicine |
US12048672B2 (en) | 2017-05-09 | 2024-07-30 | Otsuka Pharmaceutical Co., Ltd. | Packaged medicine |
CN112659693A (en) * | 2020-12-08 | 2021-04-16 | 杭州电子科技大学 | Color sensor for indicating milk deterioration and preparation method thereof |
CN112659693B (en) * | 2020-12-08 | 2022-06-17 | 杭州电子科技大学 | Color sensor for indicating milk deterioration and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
JP4018930B2 (en) | 2007-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4240888B2 (en) | Carbon dioxide detection ink composition, carbon dioxide indicator using the same, and package with carbon dioxide indicator | |
DK1909736T3 (en) | Oxygen indicator for use in drug products and package containing oxygen indicator | |
US20100224508A1 (en) | Ink composition for sensing carbon dioxide gas, carbon dioxide indicator using the same, package provided with the carbon dioxide indicator, and method for sensing pinhole using the same | |
JP4028760B2 (en) | CO2 gas detection ink composition, carbon dioxide indicator using the same, package with carbon dioxide indicator disposed therein, and pinhole detection method using the same | |
JP2003335380A (en) | Package with oxygen indicator function | |
JP2005054048A (en) | Carbon dioxide detection ink composition, carbon dioxide indicator using the same, and package with carbon dioxide indicator | |
JP4843530B2 (en) | Carbon dioxide gas indicator provided with a hydrophobic layer, and a package including the same | |
JP3903303B2 (en) | Package with pinhole detection function | |
JP3613659B2 (en) | Oxygen detector | |
JP4594356B2 (en) | Carbon dioxide indicator and package with carbon dioxide indicator | |
JP2003093474A (en) | Bicarbonate-containing chemicals contained in a package with a carbon dioxide indicator | |
JP2000288066A (en) | Eye perfusion / wash bag package | |
JP5469824B2 (en) | Carbon dioxide indicator and package | |
JP2008195445A (en) | Package with carbon dioxide indicator | |
JP2000279486A (en) | Plastic container containing medicine and pinhole detection agent | |
JP2000308669A (en) | Bicarbonate-containing chemical container package | |
JP2008088201A (en) | Ink for oxygen indicator and packaging material using the same | |
JP3090256U (en) | Multi-chamber enclosure of tissue perfusion / lavage fluid and its package | |
JP2006056963A (en) | Ink composition for oxygen detection, oxygen indicator and package equipped with oxygen indicator | |
JP2005029263A (en) | Carbon dioxide indicator, package using the same, and method of using the same | |
JP2003299712A (en) | Multi-chamber container enclosure of eye perfusion and irrigation fluid, and its package | |
WO2017141418A1 (en) | Composition for oxygen detection and oxygen detector |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040708 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070705 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070823 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070918 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070921 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4018930 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100928 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130928 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |